Maria Luisa Pineda, PhD of Envisagenics, and Maeve Wang of IAMBIC have been named honorees of Inc. Magazine’s 2025 #FemaleFounders500!
The list aims to recognize and celebrate the accomplishments of 500 female founders who are shaping the entrepreneurial landscape. The honorees are women who are considered inspiring, innovative, and tenacious role models in business.
A well deserved honor for two incredible female founders we’re thrilled are in our ecosystem!
The Center for Biotechnology is pleased to announce a request for proposals for our Research Evaluation and Commercialization Hub (REACH) award program. Awards will be in two categories: Feasibility ($50k/12mo) and Proof of Concept ($100K/12 mo.) Details on the full funding program overview and proposal guidelines can be found here.
The development of promising innovations often stalls due to limited early-stage funding to address translational uncertainties. The Center for Biotechnology’s Research Evaluation and Commercialization Hub (REACH) award program bridges the translation gap between biomedical discovery and their development toward commercial goals. Program funding is intended to determine feasibility, develop proof-of-concept, and ultimately lead to follow-on funding, a strategic partnership, or company formation.
The REACH program supports faculty and postdoctoral researchers in translating bio-based, bio-convergence, and bio-medical research discoveries by providing targeted funding and strategic guidance to bridge the translation gap between discovery and development for commercialization.
Application Deadline: May 15, 2025, 5pm ET
Learn more about the program, get information session details and access the full request for proposals here: https://centerforbiotechnology.org/what-we-do/technology-development/reach/
Stony Brook University faculty member and CFB supported researcher, Eric Brouzes, is leading a research to develop new testing methods for cervical cancer that do not require expensive equipment. The project has received a two-year grant of $50K per year from the Prevent Cancer Foundation.
Read more from SBU News: https://news.stonybrook.edu/university/new-test-for-cervical-cancer-tackles-healthcare-inequalities/
The SBV Challenge is focused on identifying high-potential, impactful cutting-edge hard tech venture concepts originating from research labs and universities on Long Island, accelerating and supporting their commercialization journey to bring impactful, equitable and sustainable solutions and products to market. The SBV Challenge is looking to support champions of hard tech innovations in Energy, Health and Information
SBV Challenge participants and winners receive mentorship and incentives to advance their technologies and accelerate their entrepreneurial journey.
Learn more and apply here: https://lihti.org/venture-champions-challenge/
The CFB was proud to support our clients, Ergami Endoscopy and FASS, who were each announced as winners of $50,000 after pitching their business plans to a panel of judges assembled by FuzeHub at the recent New York State Innovation Summit.
FuzeHub is a not-for-profit organization that supports small and medium-sized manufacturing companies in New York State, hosts this annual as part of the ESD-supported FuzeHub Jeff Lawrence Innovation Fund.
Ergami Endoscopy, based in New York City, is developing a low-cost robotic colonoscope insertion solution to improve procedure productivity; reduce patient pain and need for sedation; and reduce endoscopy-related injuries in endoscopists and nurses.
FASS is a unique syringe system that uses a rotating mechanism to switch between two needles in a single device, eliminating the need for manual switching of needles. Developed by an ER nurse after witnessing the dangers of needlestick injuries firsthand, FASS is designed to improve safety and efficiency in high-pressure environments like the ER and psychiatric units, where patients can be agitated.
Read more about the competition here.